We have world leading laboratory research programmes studying the biology and of platelets, white blood cells and endothelial cells and investigating the molecular basis of heart diseases such as atrial fibrillation. These programmes underpin strong translational research to develop and assess treatments for heart and vascular disease in both hospital and primary care settings.
Find out more about our Cardiovascular Sciences research
Inflammation and Ageing
Our partnership with the NHS brings basic scientists, clinicians and patients together to break down traditional bench to bedside divisions and allow an integrated, multidisciplinary, patient-centred approach to treating chronic inflammation and ageing. Laboratory studies of inflammation, tissue injury and scarring, and regeneration and repair are being used to develop new approaches to the diagnosis and treatment of arthritis, liver, renal and respiratory disease. Translation is accelerated through our outstanding infrastructure including the NIHR Biomedical Research Unit (BRU) in Liver Disease, the NIHR Clinical Research Facility and the Centre for Translational Inflammation research within the Queen Elizabeth Hospital.
Find out more about our Inflammation and Ageing research
Metabolism and Systems
Metabolism is vital to life and when it goes wrong this leads to a wide range of diseases. We use a variety of metabolomics approaches to study normal physiology and a range of human diseases and ageing in both experimental medicine and large-scale studies. Our research is underpinned by state of the art technology platforms featuring a unique capability for integrated metabolome analysis in the Henry Wellcome NMR Facility and the MRC-funded Phenome Centre underpinned by bioinformatics expertise. Our research is allowing us to develop new diagnostic tests and treatments for range of metabolic and endocrine disorders.
Find out more about our Metabolism and Systems research